1. Home
  2. FCUV vs APLM Comparison

FCUV vs APLM Comparison

Compare FCUV & APLM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FCUV
  • APLM
  • Stock Information
  • Founded
  • FCUV 2012
  • APLM 2016
  • Country
  • FCUV United States
  • APLM United States
  • Employees
  • FCUV N/A
  • APLM N/A
  • Industry
  • FCUV Industrial Machinery/Components
  • APLM Blank Checks
  • Sector
  • FCUV Industrials
  • APLM Finance
  • Exchange
  • FCUV Nasdaq
  • APLM Nasdaq
  • Market Cap
  • FCUV 27.6M
  • APLM 6.9M
  • IPO Year
  • FCUV N/A
  • APLM N/A
  • Fundamental
  • Price
  • FCUV $4.16
  • APLM $6.30
  • Analyst Decision
  • FCUV
  • APLM
  • Analyst Count
  • FCUV 0
  • APLM 0
  • Target Price
  • FCUV N/A
  • APLM N/A
  • AVG Volume (30 Days)
  • FCUV 16.2K
  • APLM 4.6K
  • Earning Date
  • FCUV 08-13-2025
  • APLM 08-13-2025
  • Dividend Yield
  • FCUV N/A
  • APLM N/A
  • EPS Growth
  • FCUV N/A
  • APLM N/A
  • EPS
  • FCUV N/A
  • APLM N/A
  • Revenue
  • FCUV $408,887.00
  • APLM $198,000.00
  • Revenue This Year
  • FCUV N/A
  • APLM $415.15
  • Revenue Next Year
  • FCUV N/A
  • APLM N/A
  • P/E Ratio
  • FCUV N/A
  • APLM N/A
  • Revenue Growth
  • FCUV 6.49
  • APLM N/A
  • 52 Week Low
  • FCUV $1.50
  • APLM $4.47
  • 52 Week High
  • FCUV $10.90
  • APLM $35.98
  • Technical
  • Relative Strength Index (RSI)
  • FCUV 57.13
  • APLM 51.61
  • Support Level
  • FCUV $3.75
  • APLM $5.34
  • Resistance Level
  • FCUV $4.32
  • APLM $6.70
  • Average True Range (ATR)
  • FCUV 0.24
  • APLM 0.52
  • MACD
  • FCUV 0.07
  • APLM -0.03
  • Stochastic Oscillator
  • FCUV 83.75
  • APLM 67.65

About FCUV Focus Universal Inc.

Focus Universal Inc offers smart devices, IoT products, and patented products and technologies for 5G telecommunications and network security. It is focused on commercializing its universal smart technology and financial reporting software. Its product line includes various digital, analog, and quantum light meters and filtration products, the Ubiquitor universal smart device, SEC Financial Reporting Software, and other smart devices and sensors. The company's reportable segments are Corporate and IoT, which derives maximum revenue, and Perfecular and Lusher. The Corporate and IoT segment includes its LED and IoT installation and management business (under Smart AVX), specializing in LED and display systems, home theaters, lighting control, automation, and integration.

About APLM Apollomics Inc.

Apollomics Inc is an clinical-stage biopharmaceutical company focused on the discovery and development of oncology therapies with the potential to be combined with other treatment options to harness the immune system and target specific molecular pathways to inhibit cancer. The company programs include vebreltinib (APL-101), a potent, selective c-Met inhibitor for the treatment of non-small cell lung cancer and other tumors with c-Met alterations, and uproleselan (APL-106), a specific E-Selectin antagonist that has the potential to be used adjunctively with standard chemotherapy to treat acute myeloid leukemia.

Share on Social Networks: